Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Abstract Natural killer (NK) cells are a critical component of the innate immune system. Chimeric antigen receptors (CARs) re-direct NK cells toward tumor cells carrying corresponding antigens, creating major opportunities in the fight against cancer. CAR NK cells have the potential for use as unive...
Main Authors: | Ahmet Yilmaz, Hanwei Cui, Michael A. Caligiuri, Jianhua Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-020-00998-9 |
Similar Items
-
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
by: Olaf Oberschmidt, et al.
Published: (2017-06-01) -
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
by: Xiao Wang, et al.
Published: (2022-11-01) -
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
by: Dongfang Liu, et al.
Published: (2017-05-01) -
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
by: Aline Pfefferle, et al.
Published: (2020-03-01) -
Research Progress of Chimeric Antigen Receptor NK Cells in Treatment of Lymphoma
by: HU Run, et al.
Published: (2023-12-01)